After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of Cellectar Biosciences Inc is $11.83M. A total of 0.74 million shares were traded on the day, compared to an average of 473.58K shares.
In the most recent transaction, CARUSO JAMES V bought 10,000 shares of CLRB for 4.99 per share on Jul 02 ’25. After the transaction, the Chief Executive Officer now owns 11,638 company shares. In a previous transaction on Jul 02 ’25, Longcor Jarrod bought 10,000 shares at 4.99 per share. CLRB shares that Chief Operating Officer owns now total 12,768.
Among the insiders who bought shares, Kolean Chad J acquired of 5,000 shares on Jul 02 ’25 at a per-share price of $4.99. This resulted in the Chief Financial Officer holding 6,418 shares of CLRB after the transaction. In another insider transaction, Longcor Jarrod bought 30,000 shares at $0.28 per share on Jan 10 ’25. Company shares held by the Chief Operating Officer now total 83,141.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, CLRB has a high of $68.70 and a low of $4.36.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. CLRB’s latest balance sheet shows that the firm has $35.70M in Cash & Short Term Investments as of fiscal 2021. There were $301.74k in debt and $3.99M in liabilities at the time. Its Book Value Per Share was $3.07, while its Total Shareholder’s Equity was $33.05M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CLRB is Buy with a score of 4.00.
